HAEMATO AG |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 17.3 EUR | +1.76% |
|
+1.17% | 0.00% |
| 1 week | +1.17% | ||
| Current month | +2.98% |
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Last Hours!
Take advantage of the offer
* See conditions on site
| Sales 2023 * | 270M 293M 399M | Sales 2024 * | 281M 305M 416M | Capitalization | 88.87M 96.58M 131M |
|---|---|---|---|---|---|
| Net income 2023 * | 7M 7.61M 10.35M | Net income 2024 * | 9M 9.78M 13.31M | EV / Sales 2023 * | 0.25 x |
| Net cash position 2023 * | 21.3M 23.15M 31.5M | Net cash position 2024 * | 24.3M 26.41M 35.94M | EV / Sales 2024 * | 0.23 x |
| P/E ratio 2023 * |
-
| P/E ratio 2024 * |
-
| Employees | 76 |
| Yield 2023 * |
-
| Yield 2024 * |
-
| Free-Float | 99.67% |
More Fundamentals
* Assessed data
| 1 day | +1.76% | ||
| 1 week | +1.17% | ||
| Current month | +2.98% | ||
| 1 month | +15.33% |
1 week
16.00
17.30
1 month
16.0018.00
Current year
15.0020.80
1 year
15.0020.80
3 years
15.0020.80
5 years
15.0020.80
10 years
15.0020.80
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-05-17 | 17 | -1.73% | 100 |
| 24-05-16 | 17.3 | +1.76% | 280 |
| 24-05-15 | 17 | +0.59% | 1,979 |
| 24-05-14 | 16.9 | -0.59% | 101 |
| 24-05-13 | 17 | -0.58% | 2,272 |
End-of-day quote Hanseatische Wertpapierboerse Hamburg, May 15, 2024
More quotes
Haemato AG, previously Windsor AG, is a Germany-based pharmaceutical company. The Company trades and patent-free and patent-protected medicines and generic drugs with focus on oncology, human immunodeficiency virus (HIV) and acquired immune deficiency syndrome (AIDS), neurology, rheumatology, urology, cardiovascular diseases and other chronic diseases. The Company's main markets are Europe, North America and Japan. It also imports medicines from within the European Economic Area in form of parallel imports and re-imports. The Company's subsidiaries are Haemato Pharm GmbH, Heamato Med GmbH, Castell Pharma BV, Sanate GmbH and Heamato Asia Co Ltd. Customers can order medicine through phone, fax and e-mail, among others.
Sector
Pharmaceuticals
Calendar
2024-05-19
- Q1 2024 Earnings Release (Projected)
Trading Rating
Investor Rating
ESG Refinitiv
Quarterly revenue - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| 0.00% | 96.62M | |
| +10.23% | 8.96B | |
| -10.76% | 5.19B | |
| +51.58% | 4.77B | |
| +12.50% | 4.26B | |
| -20.70% | 2.37B | |
| +12.83% | 2.3B | |
| +19.51% | 2.17B | |
| -29.65% | 2.21B | |
| -0.50% | 1.64B |
- Stock Market
- Equities
- HAEK Stock
